Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-11-23 Purchase | 2022-11-28 4:07 pm | Arcturus Therapeutics Holdings Inc. | ARCT | Payne Joseph E President and CEO | 5,000 | $16.51 | $82,550 | 1,480,097 (Direct) | View |
| 2021-05-25 Purchase | 2021-05-27 8:37 pm | Vallon Pharmaceuticals Inc. | VLON | Payne Joseph E Director | 17,500 | $4.1026 | $71,795 | 861,250 (Indirect Direct) | View |
| 2020-06-10 Purchase | 2020-06-10 9:59 pm | Arcturus Therapeutics Holdings Inc. | ARCT | Payne Joseph E President and CEO | 1,000 | $31.69 | $31,690 | 1,475,097 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-12-16 Option Award | 2024-12-18 4:06 pm | N/A 2034-12-16 | Arcturus Therapeutics Holdings Inc. | ARCT | Payne Joseph E President and CEO | 196,000 | $0 | 196,000 (Direct) | View |
| 2023-12-15 Option Award | 2023-12-19 8:00 pm | N/A 2033-12-15 | Arcturus Therapeutics Holdings Inc. | ARCT | Payne Joseph E President and CEO | 200,000 | $0 | 200,000 (Direct) | View |
| 2022-12-09 Option Award | 2022-12-13 4:07 pm | N/A 2032-12-09 | Arcturus Therapeutics Holdings Inc. | ARCT | Payne Joseph E President and CEO | 250,000 | $0 | 250,000 (Direct) | View |
| 2022-06-21 Option Award | 2022-06-23 4:16 pm | N/A 2031-12-10 | Arcturus Therapeutics Holdings Inc. | ARCT | Payne Joseph E President and CEO | 150,000 | $0 | 150,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 1:32 pm | N/A 2032-06-09 | Vallon Pharmaceuticals Inc. | VLON | Payne Joseph E Director | 7,500 | $0 | 7,500 (Direct) | View |
| 2021-05-14 Option Award | 2021-05-18 4:09 pm | N/A 2031-05-14 | Vallon Pharmaceuticals Inc. | VLON | Payne Joseph E Director | 29,286 | $0 | 29,286 (Direct) | View |
Ownership | 2021-02-10 08:31 am | N/A N/A | Vallon Pharmaceuticals Inc. | VLON | Payne Joseph E Director 10% Owner | 0 | $0 | 843,750 (Indirect) | View |
| 2020-12-18 Option Award | 2020-12-22 7:40 pm | N/A 2030-12-18 | Arcturus Therapeutics Holdings Inc. | ARCT | Payne Joseph E President and CEO 10% Owner | 175,000 | $0 | 175,000 (Direct) | View |
| 2020-02-18 Option Award | 2020-02-20 8:00 pm | N/A 2030-02-18 | Arcturus Therapeutics Holdings Inc. | ARCT | Payne Joseph E President and CEO 10% Owner | 100,000 | $0 | 100,000 (Direct) | View |